Search research articles
Contact Us
Filters
Showing results (1-10 of 174) with videos related to
Page
of 18
Sort By:
Neuro-Oncology
|
April 10, 2025
From Bench to Bedside: Novel TGFβR1 Inhibitor Shows Promise in Neurofibromatosis Treatment
Jian Wang, Rolf Bjerkvig
Cancer Treatment Reviews
|
April 13, 2012
Mesenchymal stem cell signaling in cancer progression
Anja Torsvik, Rolf Bjerkvig
Neuro-Oncology
|
June 22, 2019
Glioblastoma: a prognostic value of AMT-PET?
Rolf Bjerkvig, Frits Thorsen
Biochimica Et Biophysica Acta
|
March 22, 2007
Cancer initiation and progression: involvement of stem cells and the microenvironment
Berit B Tysnes, Rolf Bjerkvig
Expert Review of Anticancer Therapy
|
May 19, 2012
Molecular mechanisms of temozolomide resistance in glioblastoma multiforme
Tor-Christian Aase Johannessen, Rolf Bjerkvig
Neuro-Oncology
|
October 20, 2019
A new chance for EGFR inhibition in glioblastoma?
Tor-Christian Aase Johannessen, Rolf Bjerkvig
Experimental Cell Research
|
January 10, 2012
Comment to: "Spontaneous transformation of adult mesenchymal stem cells from cynomolgus macaques in vitro" by Z. Ren et al. Exp. Cell Res. 317 (2011) 2950-2957: spontaneous transformation of mesenchymal stem cells in culture: facts or fiction?
Anja Torsvik, Gro V Røsland, Rolf Bjerkvig
Current Pharmaceutical Biotechnology
|
August 8, 2002
Localised delivery of therapeutic agents to CNS malignancies: old and new approaches
Tracy-Ann Read, Frits Thorsen, Rolf Bjerkvig
International Journal of Biological Sciences
|
September 6, 2012
Spontaneous transformation of stem cells in vitro and the issue of cross-contamination
Anja Torsvik, Gro V Røsland, Rolf Bjerkvig
Oncogene
|
May 31, 2003
Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression
Ulrika Wilhelmsson, Camilla Eliasson, Rolf Bjerkvig, et al.
Page
of 18
Search research articles
Search
Showing results (1-10 of 174) with videos related to
Sort By:
Page
of 18
Neuro-Oncology
|
April 10, 2025
From Bench to Bedside: Novel TGFβR1 Inhibitor Shows Promise in Neurofibromatosis Treatment
Jian Wang, Rolf Bjerkvig
Cancer Treatment Reviews
|
April 13, 2012
Mesenchymal stem cell signaling in cancer progression
Anja Torsvik, Rolf Bjerkvig
Neuro-Oncology
|
June 22, 2019
Glioblastoma: a prognostic value of AMT-PET?
Rolf Bjerkvig, Frits Thorsen
Biochimica Et Biophysica Acta
|
March 22, 2007
Cancer initiation and progression: involvement of stem cells and the microenvironment
Berit B Tysnes, Rolf Bjerkvig
Expert Review of Anticancer Therapy
|
May 19, 2012
Molecular mechanisms of temozolomide resistance in glioblastoma multiforme
Tor-Christian Aase Johannessen, Rolf Bjerkvig
Neuro-Oncology
|
October 20, 2019
A new chance for EGFR inhibition in glioblastoma?
Tor-Christian Aase Johannessen, Rolf Bjerkvig
Experimental Cell Research
|
January 10, 2012
Comment to: "Spontaneous transformation of adult mesenchymal stem cells from cynomolgus macaques in vitro" by Z. Ren et al. Exp. Cell Res. 317 (2011) 2950-2957: spontaneous transformation of mesenchymal stem cells in culture: facts or fiction?
Anja Torsvik, Gro V Røsland, Rolf Bjerkvig
Current Pharmaceutical Biotechnology
|
August 8, 2002
Localised delivery of therapeutic agents to CNS malignancies: old and new approaches
Tracy-Ann Read, Frits Thorsen, Rolf Bjerkvig
International Journal of Biological Sciences
|
September 6, 2012
Spontaneous transformation of stem cells in vitro and the issue of cross-contamination
Anja Torsvik, Gro V Røsland, Rolf Bjerkvig
Oncogene
|
May 31, 2003
Loss of GFAP expression in high-grade astrocytomas does not contribute to tumor development or progression
Ulrika Wilhelmsson, Camilla Eliasson, Rolf Bjerkvig, et al.
Page
of 18